Ferroportin in the progression and prognosis of hepatocellular carcinoma

European Journal of Medical Research
Qin WangJiangsheng Huang

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor in men and the seventh in women and understanding the molecular mechanisms of HCC and establishing more effective therapies are critical and urgent issues. Our objective was to study the expression of ferroportin in hepatocellular carcinoma (HCC) tissue samples and the relationship between ferroportin expression and HCC characteristics. Sixty HCC tissues and their corresponding para-cancer liver tissues (PCLT) were obtained from sixty HCC patients who had undergone hepatectomy in the Second Xiangya Hospital of Central South University. Ten normal liver tissue samples were also obtained as a control. Immunohistochemistry (IHC) was performed to analyze the ferroportin expression in HCC, and the relationship between ferroportin expression and HCC clinical pathological characteristics also was analyzed. For the evaluation of IHC results, the comprehensive scoring criteria were met according to the staining intensity and the number of positive staining cells. Western blotting was performed to detect the expression level of ferroportin in HCC cell lines. Ferroportin expression in HCC tissue was significantly lower compared to PCLT and normal liver tissue (P <0.05...Continue Reading

References

Feb 10, 1983·Biochemical and Biophysical Research Communications·L ThelanderM Thelander
Mar 23, 2000·Journal of Hepatology·K Okuda
Apr 5, 2000·The Journal of Biological Chemistry·S Abboud, D J Haile
Aug 24, 2001·The Journal of Clinical Investigation·G MontosiA Pietrangelo
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Oct 22, 2003·Journal of Hepatology·Athina LymboussakiAntonello Pietrangelo
Nov 26, 2003·Blood Cells, Molecules & Diseases·Ernest BeutlerChris Vulpe
Dec 8, 2004·Current Topics in Medicinal Chemistry·Joan L BussSuzy V Torti
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Aug 6, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·François Canonne-HergauxPhilippe Gros
Aug 15, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tracy R DanielsManuel L Penichet
Aug 22, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tracy R DanielsManuel L Penichet
Sep 7, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Petra HolmströmPer Stål
Sep 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Megan WhitnallDes R Richardson
Nov 28, 2006·Carcinogenesis·Guohua ChenKostas Pantopoulos
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica BoultChris Tselepis
Aug 6, 2010·Science Translational Medicine·Zandra K PinnixFrank M Torti
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 3, 2011·Cancer Research·Suzy V Torti, Frank M Torti
Oct 5, 2011·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Dec 14, 2011·Hematology·Karin E Finberg
Jan 4, 2012·Clinical and Experimental Pharmacology & Physiology·Gregory J Anderson, Fudi Wang
May 24, 2012·International Journal of Cancer. Journal International Du Cancer·Sabrina SchlesingerUte Nöthlings

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
electrophoresis
X-ray

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.